Private equity

• Advising the GP to a private equity fund in multiple arbitrations and court proceedings in HK, Cayman Islands and the PRC relating to a USD 1 billion dispute with an investor and investments in German, Israeli and American portfolio companies. ICC, HKIAC and UNCITRAL arbitrations, HK seat, HK governing law together with HK, PRC and Cayman court proceedings with associated injunctions, disclosure orders and confidentiality orders.
• Advising a global private equity firm in multiple arbitrations relating to a USD 300 million dispute over their investment in a PRC business and joint venture dispute with the minority shareholder and numerous international court proceedings in support of the arbitrations. CIETAC arbitrations, HK law, Beijing seat together with HK, Singapore and Cayman court proceedings with associated injunctions, disclosure orders, Norwich Pharma orders and contempt of court proceedings and enforcement challenge before CICC.
• Advising a financial institution in connection with a USD 100 million dispute relating to its investment in a PRC property joint venture including steps to take control of the joint venture, information rights and redemption of shares under various rounds of investments. HKIAC arbitration and UNCITRAL arbitrations, PRC law, HK seat together with PRC court interim relief.
• Advising four private equity funds in a USD 100 million UNCITRAL arbitration together with associated Vietnamese civil and criminal proceedings. The dispute related to the funds’ investment into a group of companies in Vietnam where they became victims of a sophisticated fraud. HKIAC arbitration under UNCITRAL Rules, HK law, HK seat together with Vietnamese civil and criminal court proceedings.
• Advising two global investment banks in connection with a USD 200 million dispute relating to an investment in copper manufacturing company and the exercise of put option rights including emergency arbitration proceedings. HKIAC arbitration, HK law, HK seat.

Tech

• Advising a PRC investor in relation to a USD 2 billion dispute regarding an EV business. Including successfully defending against an emergency arbitration to force financing and also appointing professional directors to the target board of directors to prevent dissipation. HKIAC arbitration, HK law, HK seat and HKIAC emergency arbitration.
• Advising a smartphone maker in a USD 200 million arbitration relating to contractual derivative claims and copyright infringement. HKIAC arbitration, HK law and HK seat.
• Advising a company which specialises in finishing glass used on consumer electronic devices in a tech and IP related HKIAC arbitration for over USD 100 million and involving highly sensitive proprietary information. HKIAC arbitration, HK seat, HK law.
• Advising for a data centre developer and operator in relation to disputes with customers and end users in multiple jurisdictions. HKIAC arbitration and HK litigation, HK law, HK seat and related court proceedings in Singapore and England.
• Advising a large HKSE-listed software company in relation to an emergency arbitration application commenced by a significant shareholder and associated arbitration proceedings. HKIAC arbitration, HK seat, HK law.

Crypto

• Advising a high-profile owner and operator of a crypto platform in an HKIAC arbitration in relation to a crypto derivatives close-out dispute, associated Hong Kong and Seychelles court proceedings including a recent (2022) leading Hong Kong court decision on confidentiality. HKIAC arbitration, HK law, HK seat.
• Advising a crypto platform in relation to disputes against a number of early round investors. Californian court, California law and HKIAC arbitration, HK law and HK seat.
• Advising a crypto trading firm in a SIAC arbitration on potential liabilities arising from the insolvency of a crypto hedge fund. SIAC arbitration, Singapore law, Singapore seat.
• Acting for shareholders and investors in a crypto platform in relation to dissipation of assets. HK court and HKIAC arbitration, HK law, HK seat.

Pharma

• Advising an international biotechnology company in disputes relating to the acquisition of a plasma manufacturing company including issues over breaches of good manufacturing practice and regulatory issues. PRC law, HKIAC arbitration, HK seat.
• Advising in a dispute relating to an investment into a pharmaceutical business in the PRC. HKIAC arbitration, HK seat, HK law and freezing injunction in HK.
• Advising a medical devices and health care company in relation to a number of disputes relating to its divestment of an asset in the PRC. English law, ICC arbitration, London seat.
• Advising for one of the world's largest pharmaceutical companies in a litigation relating to the supply of contaminated active pharmaceutical ingredients by a PRC supplier. HK court, HK law.
• Advising a global pharmaceutical company in relation to the theft of trade secrets and Anton Piller relief. HK court, HK law.

Aviation

• Advising an international lessor in a dispute against a Hong Kong based airline for outstanding rental payments and accompanying injunctive relief to ground two aircraft pending payment. HK arbitration, HK law and HK seat together with HK court.
• Advising numerous international lessors in disputes against a major PRC regional airline including arbitration, litigation and insolvency processes. HK arbitration, HK law and HK seat together with PRC court.
• Advising an aeronautical products company in a significant ICC arbitration with one of its business partners. ICC arbitration, French law and Paris seat.
• Advising an aeronautics company in multiple arbitrations against joint venture partners. ICC arbitrations, HK law and HK seat.
• Advising a Chinese lessor in a CIETAC dispute with a Chinese airline that had failed to take delivery of an aircraft. CIETAC arbitration, Chinese law and Beijing seat and enforcement challenge before Beijing Court and a Wuxi Court.